Colorectal Cancer Clinical Trials in San Antonio

Showing 81-100 of 215 trials

A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

NCT03314935

The purpose of this open-label nonrandomized Phase 1/2 study is to evaluate INCB001158 in combination with chemotherapy in participants with advanced/metastatic solid tumors.

Biliary Tract Cancer (BTC)Colorectal Cancer (CRC)Endometrial Cancer+3 more

Incyte Corporation149 participantsStarted Nov 2017

Birmingham, Alabama, United States • Mobile, Alabama, United States • Sacramento, California, United States +7 more locations

COMPLETED< 1 mile

Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode

NCT04136002

The ECLIPSE (Evaluation of the ctDNA LUNAR test in an Average Patient Screening Episode) study is a prospective, observational multi-site study without randomization. The primary objective of the study is to evaluate the performance characteristics of a blood-based ctDNA LUNAR-2 test to detect colorectal cancer in a screen-relevant, average risk population.

Colorectal Cancer

Guardant Health, Inc.44,467 participantsStarted Oct 2019

Anniston, Alabama, United States • Guntersville, Alabama, United States • Huntsville, Alabama, United States +268 more locations

A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode

Colorectal Cancer Trials in Other Cities

Study of NKTR 255 in Combination With Cetuximab in Solid Tumors

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

Study of NIS793 and Other Novel Investigational Combinations With SOC Anti-cancer Therapy for the 2L Treatment of mCRC

Oral STAT3 Inhibitor, TTI-101, in Patients with Advanced Cancers

LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors

DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors

A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies

ColoCare Study - Colorectal Cancer Cohort

Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer

A Study to Investigate BGB-3245 (Brimarafenib) With Panitumumab in Participants With Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers

Other Conditions in San Antonio